{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T18:09:55Z","timestamp":1789582195731,"version":"build-2803163510"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.biomaterials.2024.122539","type":"journal-article","created":{"date-parts":[[2024,3,24]],"date-time":"2024-03-24T19:50:33Z","timestamp":1711309833000},"page":"122539","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Design and development of novel self-assembled catechol-modified bile acid conjugates as pH-responsive apical sodium-dependent bile acid transporter targeting nanoparticles"],"prefix":"10.1016","volume":"308","author":[{"given":"Dong-Nyeong","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seong-Bin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0851-7843","authenticated-orcid":false,"given":"Seho","family":"Kweon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-Hyuck","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyeong-Ju","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeonsu","family":"Ryu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong Wook","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5825-6266","authenticated-orcid":false,"given":"Young Jun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8632-2355","authenticated-orcid":false,"given":"Yong-Kyu","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6332-3278","authenticated-orcid":false,"given":"Jooho","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.biomaterials.2024.122539_bib1","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1002\/adma.201202343","article-title":"Catechol-based biomimetic functional materials","volume":"25","author":"Sedo","year":"2013","journal-title":"Adv. Mater."},{"issue":"1","key":"10.1016\/j.biomaterials.2024.122539_bib2","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1021\/nn203735b","article-title":"Multidentate catechol-based polyethylene glycol oligomers provide enhanced stability and biocompatibility to iron oxide nanoparticles","volume":"6","author":"Na","year":"2012","journal-title":"ACS Nano"},{"issue":"3","key":"10.1016\/j.biomaterials.2024.122539_bib3","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1002\/anie.201801063","article-title":"The chemistry behind catechol-based adhesion","volume":"58","author":"Saiz-Poseu","year":"2019","journal-title":"Angew. Chem., Int. Ed. Engl."},{"issue":"1","key":"10.1016\/j.biomaterials.2024.122539_bib4","doi-asserted-by":"crossref","first-page":"3764","DOI":"10.1038\/s41467-021-24104-w","article-title":"Preventing post-surgical cardiac adhesions with a catechol-functionalized oxime hydrogel","volume":"12","author":"Fujita","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biomaterials.2024.122539_bib5","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.actbio.2021.01.014","article-title":"Mussel-inspired poly(gamma-gl utamic acid)\/nanosilicate composite hydrogels with enhanced mechanical properties, tissue adhesive properties, and skin tissue regeneration","volume":"123","author":"Kim","year":"2021","journal-title":"Acta Biomater."},{"issue":"2","key":"10.1016\/j.biomaterials.2024.122539_bib6","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1039\/C9CS00285E","article-title":"Catechol-functionalized hydrogels: biomimetic design, adhesion mechanism, and biomedical applications","volume":"49","author":"Zhang","year":"2020","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.biomaterials.2024.122539_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2022.112879","article-title":"Catechol-functionalized sulfobetaine polymer for uniform zwitterionization via pH transition approach","volume":"220","author":"Bui","year":"2022","journal-title":"Colloids Surf. B Biointerfaces"},{"issue":"31","key":"10.1016\/j.biomaterials.2024.122539_bib8","doi-asserted-by":"crossref","first-page":"11850","DOI":"10.1021\/ja203077x","article-title":"Catechol polymers for pH-responsive, targeted drug delivery to cancer cells","volume":"133","author":"Su","year":"2011","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.biomaterials.2024.122539_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2020.111279","article-title":"Catechol-modified chitosan\/hyaluronic acid nanoparticles as a new avenue for local delivery of doxorubicin to oral cancer cells","volume":"196","author":"Pornpitchanarong","year":"2020","journal-title":"Colloids Surf., B"},{"key":"10.1016\/j.biomaterials.2024.122539_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121908","article-title":"A catechol bioadhesive for rapid hemostasis and healing of traumatic internal organs and major arteries","volume":"291","author":"Wang","year":"2022","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2024.122539_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.121272","article-title":"Bioadhesive injectable hydrogel with phenolic carbon quantum dot supported Pd single atom nanozymes as a localized immunomodulation niche for cancer catalytic immunotherapy","volume":"280","author":"He","year":"2022","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2024.122539_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2022.02.028","article-title":"Biomaterials as therapeutic drug carriers for inflammatory bowel disease treatment","volume":"345","author":"Wang","year":"2022","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.biomaterials.2024.122539_bib13","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.biomaterials.2015.02.010","article-title":"Chitosan-catechol: a polymer with long-lasting mucoadhesive properties","volume":"52","author":"Kim","year":"2015","journal-title":"Biomaterials"},{"issue":"10","key":"10.1016\/j.biomaterials.2024.122539_bib14","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1007\/s11095-007-9289-1","article-title":"Bile acid transporters: structure, function, regulation and pathophysiological implications","volume":"24","author":"Alrefai","year":"2007","journal-title":"Pharm. Res. (N. Y.)"},{"key":"10.1016\/j.biomaterials.2024.122539_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113154","article-title":"Targeting bile acid signaling for the treatment of liver diseases: from bench to bed","volume":"152","author":"Duan","year":"2022","journal-title":"Biomed. Pharmacother."},{"issue":"10","key":"10.1016\/j.biomaterials.2024.122539_bib16","doi-asserted-by":"crossref","first-page":"751","DOI":"10.2165\/00003088-200241100-00005","article-title":"Enterohepatic circulation: physiological, pharmacokinetic and clinical implications","volume":"41","author":"Roberts","year":"2002","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.biomaterials.2024.122539_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121459","article-title":"The emerging role of bile acids as critical components in nanotechnology and bioengineering: pharmacology, formulation optimizers and hydrogel-biomaterial applications","volume":"283","author":"Kovacevic","year":"2022","journal-title":"Biomaterials"},{"issue":"4","key":"10.1016\/j.biomaterials.2024.122539_bib18","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1124\/pr.113.008201","article-title":"Bile acid signaling in metabolic disease and drug therapy","volume":"66","author":"Li","year":"2014","journal-title":"Pharmacol. Rev."},{"issue":"3","key":"10.1016\/j.biomaterials.2024.122539_bib19","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.jhep.2015.10.024","article-title":"Inhibition of intestinal bile acid absorption improves cholestatic liver and bile duct injury in a mouse model of sclerosing cholangitis","volume":"64","author":"Baghdasaryan","year":"2016","journal-title":"J. Hepatol."},{"issue":"6","key":"10.1016\/j.biomaterials.2024.122539_bib20","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1111\/acer.14619","article-title":"Gut-restricted apical sodium-dependent bile acid transporter inhibitor attenuates alcohol-induced liver steatosis and injury in mice","volume":"45","author":"Matye","year":"2021","journal-title":"Alcohol Clin. Exp. Res."},{"issue":"357","key":"10.1016\/j.biomaterials.2024.122539_bib21","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaf4823","article-title":"Inhibition of ileal bile acid uptake protects against nonalcoholic fatty liver disease in high-fat diet-fed mice","volume":"8","author":"Rao","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.biomaterials.2024.122539_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119120","article-title":"Bile acid transporter mediated STC\/Soluplus self-assembled hybrid nanoparticles for enhancing the oral drug bioavailability","volume":"579","author":"Zhang","year":"2020","journal-title":"Int. J. Pharm."},{"issue":"3","key":"10.1016\/j.biomaterials.2024.122539_bib23","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1097\/HEP.0000000000000376","article-title":"A3907, a systemic ASBT inhibitor, improves cholestasis in mice by multiorgan activity and shows translational relevance to humans","volume":"78","author":"Caballero-Camino","year":"2023","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.biomaterials.2024.122539_bib24","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/hep.20295","article-title":"Bile acid-induced negative feedback regulation of the human ileal bile acid transporter","volume":"40","author":"Neimark","year":"2004","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.biomaterials.2024.122539_bib25","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1021\/mp060022d","article-title":"Apical sodium dependent bile acid transporter (ASBT, SLC10A2): a potential prodrug target","volume":"3","author":"Balakrishnan","year":"2006","journal-title":"Mol. Pharm."},{"issue":"21","key":"10.1016\/j.biomaterials.2024.122539_bib26","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202201414","article-title":"Bile acid conjugation on solid nanoparticles enhances ASBT-mediated endocytosis and chylomicron pathway but weakens the transcytosis by inducing transport flow in a cellular negative feedback loop","volume":"9","author":"Deng","year":"2022","journal-title":"Adv. Sci."},{"issue":"8","key":"10.1016\/j.biomaterials.2024.122539_bib27","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1021\/acs.bioconjchem.5b00230","article-title":"Design, synthesis, and therapeutic evaluation of poly(acrylic acid)-tetraDOCA conjugate as a bile acid transporter inhibitor","volume":"26","author":"Park","year":"2015","journal-title":"Bioconjugate Chem."},{"issue":"7369","key":"10.1016\/j.biomaterials.2024.122539_bib28","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1038\/nature10450","article-title":"Crystal structure of a bacterial homologue of the bile acid sodium symporter ASBT","volume":"478","author":"Hu","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.biomaterials.2024.122539_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.120944","article-title":"Effective oral delivery of Exenatide-Zn(2+) complex through distal ileum-targeted double layers nanocarriers modified with deoxycholic acid and glycocholic acid in diabetes therapy","volume":"275","author":"Han","year":"2021","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.biomaterials.2024.122539_bib30","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s12876-016-0481-9","article-title":"BAT117213: ileal bile acid transporter (IBAT) inhibition as a treatment for pruritus in primary biliary cirrhosis: study protocol for a randomised controlled trial","volume":"16","author":"Hegade","year":"2016","journal-title":"BMC Gastroenterol."},{"issue":"2","key":"10.1016\/j.biomaterials.2024.122539_bib31","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jhep.2020.03.024","article-title":"g. Volixibat in Adults study, Volixibat in adults with non-alcoholic steatohepatitis: 24-week interim analysis from a randomized, phase II study","volume":"73","author":"Newsome","year":"2020","journal-title":"J. Hepatol."},{"issue":"11","key":"10.1016\/j.biomaterials.2024.122539_bib32","article-title":"Systemic ASBT inactivation protects against liver damage in obstructive cholestasis in mice","volume":"4","author":"Kunst","year":"2022","journal-title":"JHEP Rep"},{"issue":"9","key":"10.1016\/j.biomaterials.2024.122539_bib33","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.3390\/cells10092437","article-title":"Chenodeoxycholic acid pharmacology in biotechnology and transplantable pharmaceutical applications for tissue delivery: an acute preclinical study","volume":"10","author":"Mooranian","year":"2021","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.biomaterials.2024.122539_bib34","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1021\/acs.molpharmaceut.7b01091","article-title":"Bile acid-based drug delivery systems for enhanced doxorubicin encapsulation: comparing hydrophobic and ionic interactions in drug loading and release","volume":"15","author":"Cunningham","year":"2018","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.biomaterials.2024.122539_bib35","doi-asserted-by":"crossref","first-page":"4423","DOI":"10.2147\/DDDT.S328526","article-title":"The effects of primary unconjugated bile acids on nanoencapsulated pharmaceutical formulation of hydrophilic drugs: pharmacological implications","volume":"15","author":"Mooranian","year":"2021","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.biomaterials.2024.122539_bib36","doi-asserted-by":"crossref","first-page":"7719","DOI":"10.2147\/IJN.S267424","article-title":"Improvements in the oral absorption and anticancer efficacy of an oxaliplatin-loaded solid formulation: pharmacokinetic properties in rats and nonhuman primates and the effects of oral metronomic dosing on colorectal cancer","volume":"15","author":"Pangeni","year":"2020","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.biomaterials.2024.122539_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121584","article-title":"Metronomic dose-finding approach in oral chemotherapy by experimentally-driven integrative mathematical modeling","volume":"286","author":"Kweon","year":"2022","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.biomaterials.2024.122539_bib38","first-page":"83","article-title":"Design of chimeric GLP-1A using oligomeric bile acids to utilize transporter-mediated endocytosis for oral delivery, Biomater","volume":"27","author":"Kweon","year":"2023","journal-title":"Res."},{"issue":"18","key":"10.1016\/j.biomaterials.2024.122539_bib39","doi-asserted-by":"crossref","first-page":"18074","DOI":"10.1021\/acsnano.3c04793","article-title":"Oral delivery of gemcitabine-loaded glycocholic acid-modified micelles for cancer therapy","volume":"17","author":"Zang","year":"2023","journal-title":"ACS Nano"},{"issue":"3","key":"10.1016\/j.biomaterials.2024.122539_bib40","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1053\/jhep.2002.36088","article-title":"Ursodeoxycholic acid in cholestatic liver disease: mechanisms of action and therapeutic use revisited","volume":"36","author":"Paumgartner","year":"2002","journal-title":"Hepatology"},{"issue":"W1","key":"10.1016\/j.biomaterials.2024.122539_bib41","doi-asserted-by":"crossref","first-page":"W325","DOI":"10.1093\/nar\/gkx277","article-title":"TRAPP webserver: predicting protein binding site flexibility and detecting transient binding pockets","volume":"45","author":"Stank","year":"2017","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.biomaterials.2024.122539_bib42","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13062-020-00267-2","article-title":"AMDock: a versatile graphical tool for assisting molecular docking with Autodock Vina and Autodock4","volume":"15","author":"Valdes-Tresanco","year":"2020","journal-title":"Biol. Direct"},{"issue":"1","key":"10.1016\/j.biomaterials.2024.122539_bib43","doi-asserted-by":"crossref","first-page":"16","DOI":"10.15430\/JCP.2017.22.1.16","article-title":"Ursodeoxycholic acid induces death receptor-mediated apoptosis in prostate cancer cells","volume":"22","author":"Lee","year":"2017","journal-title":"J. Cancer Prev."},{"issue":"5","key":"10.1016\/j.biomaterials.2024.122539_bib44","first-page":"2551","article-title":"Synergistic effect of ursodeoxycholic acid on the antitumor activity of sorafenib in hepatocellular carcinoma cells via modulation of STAT3 and ERK","volume":"42","author":"Lee","year":"2018","journal-title":"Int. J. Mol. Med."},{"issue":"6","key":"10.1016\/j.biomaterials.2024.122539_bib45","first-page":"G1118","article-title":"Transepithelial transport of cholyltaurine by caco-2 cell monolayers is sodium-dependent","volume":"264","author":"Chandler","year":"1993","journal-title":"Am. J. Physiol."},{"issue":"1","key":"10.1016\/j.biomaterials.2024.122539_bib46","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0304-4165(90)90179-Z","article-title":"Transport of bile acids in a human intestinal epithelial cell line, Caco-2","volume":"1035","author":"Hidalgo","year":"1990","journal-title":"Biochim. Biophys. Acta, Gen. Subj."},{"key":"10.1016\/j.biomaterials.2024.122539_bib47","doi-asserted-by":"crossref","first-page":"4163","DOI":"10.1038\/srep04163","article-title":"Functional transformations of bile acid transporters induced by high-affinity macromolecules","volume":"4","author":"Al-Hilal","year":"2014","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biomaterials.2024.122539_bib48","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.biomaterials.2017.09.022","article-title":"Bile acid transporter mediated endocytosis of oral bile acid conjugated nanocomplex","volume":"147","author":"Park","year":"2017","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.biomaterials.2024.122539_bib49","first-page":"5","article-title":"Transcellular vesicular transport in epithelial and endothelial cells: challenges and opportunities","volume":"19","author":"Fung","year":"2018","journal-title":"Traffic (Oxford, U. K.)"},{"issue":"1","key":"10.1016\/j.biomaterials.2024.122539_bib50","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1186\/s12951-022-01460-3","article-title":"Biomimetic and temporal-controlled nanocarriers with ileum transporter targeting for achieving oral administration of chemotherapeutic drugs","volume":"20","author":"Liu","year":"2022","journal-title":"J. Nanobiotechnol."},{"issue":"7916","key":"10.1016\/j.biomaterials.2024.122539_bib51","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1038\/s41586-022-04857-0","article-title":"Structural insights into the HBV receptor and bile acid transporter NTCP","volume":"606","author":"Park","year":"2022","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.biomaterials.2024.122539_bib52","doi-asserted-by":"crossref","first-page":"5094","DOI":"10.1021\/jm400459m","article-title":"Discovery of a highly potent, nonabsorbable apical sodium-dependent bile acid transporter inhibitor (GSK2330672) for treatment of type 2 diabetes","volume":"56","author":"Wu","year":"2013","journal-title":"J. Med. Chem."}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961224000735?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961224000735?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T21:24:14Z","timestamp":1738099454000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961224000735"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":52,"alternative-id":["S0142961224000735"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2024.122539","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design and development of novel self-assembled catechol-modified bile acid conjugates as pH-responsive apical sodium-dependent bile acid transporter targeting nanoparticles","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2024.122539","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"122539"}}